Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies

BACKGROUND AND OBJECTIVE: Saroglitazar is a newer antidiabetic agent approved to manage dyslipidemia. The objective is tevaluate the efficacy and safety profiles of saroglitazar in patients with dyslipidemia. METHODS: A systematic search was conducted using PubMed, Cochrane Library, Scopus, and Goog...

Descripción completa

Detalles Bibliográficos
Autores principales: Chhabra, Manik, Vidyasagar, Kota, Gudi, Sai Krishna, Sharma, Jatin, Sharma, Rishabh, Rashid, Muhammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249226/
https://www.ncbi.nlm.nih.gov/pubmed/35776741
http://dx.doi.org/10.1371/journal.pone.0269531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249226/
https://www.ncbi.nlm.nih.gov/pubmed/35776741
http://dx.doi.org/10.1371/journal.pone.0269531

Ejemplares similares